Cirrhosis Research Studies
Investigators
Open Research Studies for Cirrhosis
ALC Database
Enrolling: Yes
Principle Investigator: Craig Lammert, MD
Duration: 1 visit
Patient Population: Alcoholic liver cirrhosis, no viral hepatitis, pre/post transplant.
Interested in this study? Please contact the following coordinator:
Kelsey Green
greenke@iu.edu
(317) 278-9292
The Cirrhosis Medical Home
Enrolling: Yes
Principle Investigator: Eric Orman, MD
Duration: Patients are enrolled for 6 months - total study duration is 2 years.
Patient Population: Patients with cirrhosis who have recently been discharged from the hospital and their caregivers.
Interested in this study? Please contact the following coordinator:
Elizabeth Peek
peeke@iu.edu
(317) 278-9303
Cirrhosis OP QoL
Enrolling: Yes
Principle Investigator: Archita Desai, MD
Duration: 3 -5 years
Patient Population: Patients over the age of 18 with cirrhosis.
Interested in this study? Please contact the following coordinator:
Logan Hobbs
lshobbs@iu.edu
(317) 274-8422
Cirrhosis Readmit. Inpatient
Enrolling: Yes
Principle Investigator: Archita Desai, MD
Duration: 3 - 5 years
Patient Population: Inpatients over the age of 18 with cirrhosis.
Interested in this study? Please contact the following coordinator:
Logan Hobbs
lshobbs@iu.edu
(317) 274-8422
Galectin - Phase 2b/3
Enrolling: TBD
Principle Investigator: Raj Vuppalanchi, MD
Duration: 52 week treatment period with possibility of 52 additional weeks.
Patient Population: Patients 18-75 years old with NASH cirrhosis and no varices.
Drug(s): Belapectin every 2 week infusion.
Interested in this study? Please contact the coordinator below:Mandy Cruz
mandcruz@iu.edu
(317) 278-6215
HRQoL Comparison
Enrolling: Yes
Principle Investigator: Naga Chalasani, MD
Duration: 3 - 5 years
Patient Population: Patients that are over 18 years old with liver disease.
Interested in this study? Please contact the following coordinator:
Logan Hobbs
lshobbs@iu.edu
(317) 274-8422
ICU Study
Enrolling: Yes
Principle Investigator: Kavish Patidar, DO
Duration: 5 years
Patient Population: Adults over the age of 18 with a diagnosis of cirrhosis admitted to the ICU.
Interested in this study? Please contact the following coordinator:
Casey Snoddy
casnoddy@iu.edu
(317) 278-8118
Midwest Cirrhosis Consortium
Enrolling: Yes
Principle Investigators: Marwan Ghabril, MD and Eric Orman, MD
Duration: 1 visit
Patient Population: Adults over the age of 18 with a diagnosis of cirrhosis admitted to the ICU, PCU and wards as an inpatient.
Inerested in this study? Please contact the following coordinator:
Jake McCarty
jacmccar@iu.edu
(317) 278-6305
Safety and Efficacy of Ketogenic Diet for PromotingWeight Loss in Obese Individuals with Compensated NASH Cirrhosis
Enrolling: Yes
Principle Investigator: Raj Vuppalanchi, MD
Duration: 16 weeks
Patient Population: Patients over the age of 18 with a diagnosis of NASH cirrhosis with a BMI >30kg/m2.
Interested in this study? Please contact the following coordinator:
Casey Snoddy
casnoddy@iu.edu
(317) 278-8118
Tocotrienol
Enrolling: Yes
Principle Investigator: Raj Vuppalanchi, MD
Duration: 3 years
Patient Population: Compensated or decompensated with only 1 symptom of decompensation of NASH cirrhosis with MELD score 10-15.
Drug(s): Tocovid/tocotrienol
Interested in this study? Please contact the coordinator below:
Heather Adams
hadams3@IUHealth.org
(317) 962-1130
Closed Cirrhosis Studies
-
Cirrhotic Database
Enrolling: No
Duration: 1 visit.
-
UCD Database
Enrolling: No
Duration: 1 visit.